AMBUBC Stock Overview
A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 115.45 |
| 52 Week High | DKK 150.95 |
| 52 Week Low | DKK 94.37 |
| Beta | 0.79 |
| 11 Month Change | -8.95% |
| 3 Month Change | -16.78% |
| 1 Year Change | n/a |
| 33 Year Change | -38.33% |
| 5 Year Change | -1.28% |
| Change since IPO | 801.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMBUBC | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -10.7% | 7.7% | -0.4% |
| 1Y | n/a | -2.1% | 5.6% |
Return vs Industry: Insufficient data to determine how AMBUBC performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how AMBUBC performed against the UK Market.
Price Volatility
| AMBUBC volatility | |
|---|---|
| AMBUBC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: AMBUBC's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine AMBUBC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,196 | Britt Jensen | www.ambu.com |
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBUBC fundamental statistics | |
|---|---|
| Market cap | DKK 30.50b |
| Earnings (TTM) | DKK 235.00m |
| Revenue (TTM) | DKK 5.39b |
129.8x
P/E Ratio5.7x
P/S RatioIs AMBUBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBUBC income statement (TTM) | |
|---|---|
| Revenue | DKK 5.39b |
| Cost of Revenue | DKK 2.19b |
| Gross Profit | DKK 3.20b |
| Other Expenses | DKK 2.97b |
| Earnings | DKK 235.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 59.38% |
| Net Profit Margin | 4.36% |
| Debt/Equity Ratio | 0% |
How did AMBUBC perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield43%
Payout RatioDoes AMBUBC pay a reliable dividends?
See AMBUBC dividend history and benchmarks| Ambu dividend dates | |
|---|---|
| Ex Dividend Date | Dec 05 2024 |
| Dividend Pay Date | Dec 09 2024 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 20 days |
Does AMBUBC pay a reliable dividends?
See AMBUBC dividend history and benchmarks